Positioning device for ostial lesions

FIELD AND BACKGROUND OF THE INVENTION

The present invention relates to a positioning device for ostial lesions and, more particularly to a device that can be attached to a catheter to aid in positioning of the catheter at an ostial lesion. The present invention also relates to vessel treatment devices and methods and, more particularly, to catheter systems having low profiles and predictable positioning capabilities, both rotationally and translationally.

Several problems are associated with known prior art stent delivery devices, particularly ones which are suitable for treating bifurcation lesions. First, they generally have large outer diameters, particularly since the known designs usually include two guidewire lumens—one for a main guidewire and one for a side branch guidewire. The relatively large profiles of currently known systems cause difficulties in maneuverability and access to the site. Furthermore, the presence of two guidewires often results in wire entanglement, making the procedure difficult to perform without multiple insertions and retractions. Another problem which persists in these devices is inaccurate positioning within the vessel. This problem has been addressed with the use of radiopaque markers placed in strategic locations. However, visualization is done in the two-dimensional plane, while the actual procedure takes place within the three-dimensional realm. As such, inaccurate deployment is commonplace, often resulting in either stent jailing or insufficient coverage.

An example of a prior art bifurcation stent delivery system is disclosed in U.S. Pat. No. 6,048,361 to Von Oepen. The system includes a stent with an increased radial opening and a balloon catheter on which the stent is mounted, the balloon catheter having a hollow chamber for passage of a guiding wire so that it exits in a center of the increased opening. The system disclosed therein includes two passageways for guidewires, necessitating a relatively large outer diameter. Furthermore, the presence of two wires can lead to problems of wire entanglement.

Other examples of prior art bifurcation stent delivery systems and methods are disclosed in U.S. Pat. No. 6,692,483 to Vardi et al. and U.S. Patent Application Publication No. 2001/0049548 to Vardi et al. These include a balloon catheter having a main guidewire lumen and a flexible side sheath having a side branch lumen. The method disclosed aims to reduce wire entanglement by first inserting one of the guidewires, then advancing the system, and finally advancing the second guidewire. Alternatively, one of the guidewires is housed within the system and only released once the system is in place. However, problems of wire entanglement may also occur upon removal of the system. Furthermore, the system disclosed therein is prone to overshooting of the bifurcation, resulting in sub-optimal placement. Finally, the dual lumen configuration results in a relatively large profile for the overall system.

Other similar examples of prior art bifurcation stent delivery systems are disclosed in U.S. Pat. No. 5,749,825 to Fischell et al. and U.S. Pat. No. 6,682,556 to Ischinger. The systems disclosed therein include balloon catheters with side branch tubes, and require two guidewires: one for the main vessel and one for the branch vessel. Similar to the aforementioned prior art, large profile, wire entanglement, and inaccurate positioning are potential problems.

A prior art device which aims to provide improved rotational orientation while avoiding wire entanglement is disclosed in U.S. Patent Application Publication No. 2003/0055483 to Gumm. Gumm discloses a catheter assembly having a rotatably mounted balloon, and further including a side branch hollow member attached to the catheter balloon. A noted feature of the device is the use of rotating members sealed to opposite ends of the balloon. Thus, the side branch hollow member, the balloon and the rotating members act as a unit which rotates freely relative to the main hypotube. This particular feature is considered an integral part of the design, providing improved orientation of the stent relative to the side branch at the bifurcation. However, this feature also results in an increased overall diameter of the system. Furthermore, it does not provide a way to accurately position the stent in the translational plane.

Attempts have been made to reduce the profile of a single stent delivery device by using a fixed wire balloon catheter, such as is disclosed in U.S. Patent Application Publication No. 2002/0147491 to Khan et al. The device disclosed therein includes either a short section of guidewire fixedly attached to the distal end of a balloon, or a core wire that extends within the system. This design reduces the profile of the system as compared to prior art devices by eliminating the inner guidewire lumen. However, the system disclosed therein does not teach or suggest the possibility of bifurcation stenting, nor does it provide rapid exchange capabilities.

There is thus a widely recognized need for, and it would be highly advantageous to have, a stent delivery system devoid of the above limitations.

Treating a lesion at an ostium is often challenging, due to the difficulty in positioning of a treatment device, such as a stent. Often, placement is too far within the branch vessel, preventing treatment of the lesion. At other times, placement is not far enough within the branch vessel, causing the stent to protrude into the main vessel. The aorta presents additional challenges since it is not visible during insertion of the treatment device.

Prior art devices designed for positioning stents in an ostial lesion are often undesirable since the positioning portion is incorporated within the delivery device or the stent, requiring the user to purchase the entire device. It would thus be beneficial to have a stand-alone device for positioning of any suitable delivery system in a ostial lesion.

An example of a stand-alone device is disclosed in U.S. Patent Application Publication No. 2005/0101968 to Dadourian. There is disclosed an ostial locator wire attached to a catheter wherein a selectively deployable expandable section of the ostial locator wire encircles the interventional device. A disadvantage of the device disclosed in Dadourian is that the ostial locator wire, when encircling the catheter, can become entangled with a stent placed thereon. Moreover, the wire is attached to the catheter via a sheath having a lumen and a fastener, which adds to the overall profile of the system.

SUMMARY OF THE INVENTION

According to the present invention, there is provided a catheter system including a catheter body with a catheter proximal end and a catheter distal end, a balloon positioned on the catheter distal end, the balloon having a balloon proximal end and a balloon distal end, a guidewire lumen attached to the balloon distal end, the guidewire lumen having a length of less than 15 mm, and a guidewire enclosure having an enclosure distal end and an enclosure proximal end, and at least partially attached to the catheter body.

According to further features in preferred embodiments, the catheter system further includes a stent positioned on the balloon. The stent has either a dedicated side opening or regular openings, and the enclosure distal end is positionable at or through the side opening or openings. In a preferred embodiment, the balloon in its deflated configuration has a temporary lumen for receiving a guidewire therethrough, and the temporary lumen is preferably longitudinally aligned with the guidewire lumen, such that a distal end of the guidewire is positionable through the guidewire lumen and a portion of the guidewire which is proximal to the distal end of the guidewire is positionable in the temporary lumen. According to further features, the balloon in a deflated configuration has an “S” shape having an upper curved portion and a lower curved portion, wherein the lower curved portion is a containment area for holding a guidewire therein. In alternative embodiments, the balloon in a deflated configuration has a hooked “Y” shape, wherein a bottom portion of the “Y” shape is hooked so as to form a containment area for holding a guidewire therein. The “Y” shape may further include two upper arms which form a secondary containment area for holding the guidewire enclosure therein. In a preferred embodiment, the temporary lumen and the guidewire lumen are on an opposite side from the guidewire enclosure. According to additional features, the guidewire enclosure is at least partially positioned within the catheter body and is attached to the catheter body at a location on the balloon. The location of attachment is approximately in a center of the balloon.

According to a further aspect of the present invention, there is provided a method for treating a lesion in a vessel. The method includes providing a catheter system having a catheter body with a balloon on a distal end thereof, a guidewire lumen attached to a distal end of the balloon, a guidewire enclosure at least partially attached to the catheter; and a guidewire positioned through the guidewire lumen and through a temporary lumen in the balloon such that the guidewire is immovable with respect to the catheter body, introducing a tracking guidewire having a distal end and a proximal end into the vessel, positioning the proximal end of the tracking guidewire in the guidewire enclosure, advancing the catheter over the tracking guidewire until the catheter reaches the lesion, and inflating the balloon thereby releasing the guidewire from the temporary lumen.

According to yet another aspect of the invention, there is provided a catheter system including a catheter body having a catheter proximal end and a catheter distal end, a fixed wire balloon positioned at the catheter distal end and having a working length portion having a substantially uniform diameter, a proximal narrowed portion proximal to the working length portion having a smaller diameter than the substantially uniform diameter of the working length portion, and a distal narrowed portion distal to the working length portion having a smaller diameter than the substantially uniform diameter of the working length portion, and a guidewire enclosure having an enclosure proximal end and an enclosure distal end, the guidewire enclosure at least partially attached to the catheter at an attachment point, wherein the attachment point is located proximal to said working length portion of said fixed wire balloon.

According to further features in preferred embodiments of the present invention, the guidewire enclosure is at least partially positioned within the catheter body. The attachment point is at or proximal to the enclosure distal end. In one preferred embodiment, the catheter system further includes a guidewire positionable within the guidewire enclosure. According to further features, at least a portion of the catheter body is comprised of a rigid material thereby providing a rigid control area, and the catheter system further includes a substantially rigid core wire positioned through the fixed wire balloon and connecting the balloon distal end and the rigid control area.

According to yet another aspect of the present invention, there is provided a method for treating a lesion in a vessel. The method includes introducing a guidewire into the vessel and through the lesion, providing a catheter having a fixed wire balloon and a guidewire enclosure attached to a proximal end of the fixed wire balloon, introducing a proximal end of the guidewire into the guidewire enclosure of the catheter, advancing the catheter over the guidewire until a distal end of the catheter is at the lesion and the guidewire is positioned alongside the balloon, and inflating the balloon so as to compress the guidewire into the lesion.

In one embodiment, the method further includes treating a lesion in a second vessel, the second vessel being connected to the first vessel at a bifurcation. The method includes at least partially deflating the balloon, retracting the catheter along the guidewire, introducing the catheter into the second vessel, and inflating the balloon.

According to yet another aspect of the invention there is provided a method for treating a first lesion in a first vessel and a second lesion in a second vessel, the first and second vessel connected at a bifurcation. The method includes introducing a guidewire into the second vessel, providing a catheter having a fixed wire balloon and a guidewire enclosure attached to a proximal end of the fixed wire balloon, introducing a proximal end of the guidewire into the guidewire enclosure of the catheter, advancing the catheter over the guidewire until a distal end of the catheter reaches the bifurcation, further advancing the catheter past the bifurcation and into the first vessel such that the balloon is positioned alongside the first lesion, inflating the balloon, deflating the balloon, retracting the catheter over the guidewire, introducing the catheter into the second vessel, such that the guidewire is positioned alongside the balloon, and inflating the balloon so as to compress the guidewire into the second lesion.

According to yet another aspect of the invention, there is provided a method for treating an intracranial aneurysm in a vessel. The method includes providing a catheter having a fixed wire balloon, an auxiliary elongated element at least partially attached to the balloon, and a stent positioned on the balloon and having a side opening, wherein the elongated element is positioned at the side opening, introducing the catheter into the vessel, positioning the catheter such that said the side opening is situated at the aneurysm, deploying the stent, removing the catheter, and introducing a coil delivery system for introduction of an embolic coil into the aneurysm.

According to one aspect of the present invention, there is provided a stand-alone device for positioning of a catheter at an ostium. The device includes an anchoring portion configured to be directly attached to the catheter at a location proximal to a treatment device positioned on the catheter, the anchoring portion having a proximal end, a distal end and a longitudinal axis extending from the proximal end to the distal end, and an expandable portion extending from the distal end of the anchoring portion, the expandable portion immovable with respect to the anchoring portion along the longitudinal axis, the expandable portion configured to extend outwardly with respect to the longitudinal axis and configured to be bendable in a direction of the proximal end of the anchoring portion.

According to further aspects of the present invention, there is provided a method for positioning of a catheter in the ostium of a vessel branching off from a main vessel. The method includes providing a device having an anchoring portion and an expandable portion, the anchoring portion configured to be attached to a catheter shaft, and the expandable portion located at a distal end of the anchoring portion and configured to extend outwardly with respect to a longitudinal axis of the anchoring portion, providing a catheter having a shaft along its length and a treatment device at a distal end thereof, attaching the anchoring portion to the shaft of the catheter such that the anchoring portion and the expandable portion are positioned proximal to the treatment device, positioning a guiding catheter in a vessel to a location proximal to the ostium, placing a guidewire through the guiding catheter and into the ostium, advancing the catheter with the device attached thereto over the guidewire and through the guiding catheter, wherein the expandable portion is folded back proximally within the guiding catheter, advancing the catheter with the device attached thereto past a distal end of the guiding catheter, causing the expandable portion to be released from the guiding catheter and to extend outwardly with respect to the longitudinal axis of the anchoring portion, pushing the catheter into the ostial vessel until the expandable portion pushes against a wall of the main vessel at the ostium, preventing further advancement of the catheter, deploying the treatment device once the catheter is in position in the ostial vessel, and pulling the catheter and the attached treatment device proximally through the guiding catheter.

Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, suitable methods and materials are described below. In case of conflict, the patent specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and not intended to be limiting.

BRIEF DESCRIPTION OF THE DRAWINGS

The invention is herein described, by way of example only, with reference to the accompanying drawings. With specific reference now to the drawings in detail, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of the preferred embodiments of the present invention only, and are presented in the cause of providing what is believed to be the most useful and readily understood description of the principles and conceptual aspects of the invention. In this regard, no attempt is made to show structural details of the invention in more detail than is necessary for a fundamental understanding of the invention, the description taken with the drawings making apparent to those skilled in the art how the several forms of the invention may be embodied in practice.

FIG. 1 is an illustration of a first type of vessel bifurcation with plaque buildup;

FIG. 2 is an illustration of a prior art bifurcation stent delivery system;

FIG. 3 is an illustration of a bifurcation stent delivery system in accordance with a preferred embodiment of the present invention;

FIGS. 4
a-d are illustrations of the system of FIG. 3 shown without a stent;

FIG. 5 is an illustration of the system of FIG. 3 in position at a bifurcation;

FIG. 6 is an illustration of a the system of FIG. 3, shown without a stent, and further including a distal connecting element;

FIG. 7 is an illustration of a bifurcation stent delivery system, shown without a stent, in accordance with another embodiment of the present invention;

FIG. 8 is an illustration of a bifurcation stent delivery system, shown without a stent, in accordance with yet another embodiment of the present invention;

FIGS. 9
a and 9b are illustrations of a bifurcation stent delivery system in accordance with another embodiment of the present invention;

FIG. 10 is an illustration of a second type of vessel bifurcation with plaque buildup;

FIGS. 11
a-c are illustrations of a system for treating a bifurcation such as the one depicted in FIG. 10;

FIG. 12 is an illustration of the system of FIG. 11a in position at a bifurcation;

FIG. 13 is an illustration of a third type of vessel bifurcation with plaque buildup;

FIGS. 14
a and b are illustrations of a system for treating a bifurcation such as the one depicted in FIG. 13;

FIGS. 15
a and b are illustrations of the system of FIG. 14, further including a holder;

FIGS. 16
a and b are illustrations of the system of FIG. 14, further including a holder, in an alternative embodiment;

FIG. 17 is an illustration of the system of FIG. 14 being introduced into a guiding catheter;

FIGS. 18
a-c are illustrations of the system of FIG. 14 during positioning and deployment;

FIG. 19 is an illustration of a fourth type of vessel bifurcation with plaque buildup;

FIG. 20 is an illustration of a system, shown without a stent, for treating a bifurcation such as the one depicted in FIG. 19;

FIG. 21 is an illustration of the system depicted in FIG. 20, further including stents thereon;

FIGS. 22
a-d are illustrations of a method of deploying the system of FIG. 20;

FIG. 23 is an illustration of a tapered balloon system with a side branch lumen, in accordance with another embodiment of the present invention;

FIGS. 24
a-c are illustrations of different embodiments of a system for delivery of a stent at a Type 3 bifurcation lesion or at a non-bifurcated lesion;

FIG. 25 is an illustration of the system of FIG. 24a in place at a bifurcation;

FIG. 26 is an illustration of the system of FIG. 24a in place at a non-bifurcated lesion;

FIGS. 27
a-d are illustrations of a configuration of markers;

FIG. 28 is an illustration of a specific shape configuration of markers;

FIGS. 29
a-f are illustrations of different types of bifurcation lesions;

FIGS. 30A-30E are illustrations of steps of a method of treating an intracranial aneurysm, in accordance with embodiments of the present invention;

FIGS. 31A and 31B are cross-sectional illustrations of a balloon in its deflated state and having a guidewire positioned within a temporary lumen, in accordance with embodiments of the present invention;

FIG. 32 is an illustration of a system without a stent, in accordance with embodiments of the present invention; and

FIG. 33
a is a schematic illustration of a device for positioning of a catheter in an ostial lesion;

FIG. 33
b is a cross-sectional view of the device of FIG. 33a;

FIG. 34
a is a schematic illustration of the device of FIG. 33a positioned on a catheter;

FIG. 34
b is a cross-sectional view of the device of FIG. 34a;

FIG. 35
a is a schematic illustration of the device of FIG. 33a having a double helix configuration and an expanded diameter in accordance with one embodiment of the present invention;

FIG. 35
b is a schematic illustration of the device of FIG. 35a having a minimized diameter;

FIG. 36
a is a schematic illustration of the device of FIG. 33a having a stent-like configuration and an expanded diameter in accordance with another embodiment of the present invention;

FIG. 36
b is a schematic illustration of the device of FIG. 36a having a minimized diameter;

FIG. 37
a is a schematic illustration of the device of FIG. 33a having a braided configuration and an expanded diameter in accordance with another embodiment of the present invention;

FIG. 37
b is a schematic illustration of the device of FIG. 37a having a minimized diameter;

FIG. 38
a is a schematic illustration of the device of FIG. 33a having a coil configuration and an expanded diameter in accordance with another embodiment of the present invention;

FIG. 38
b is a schematic illustration of the device of FIG. 38a having a minimized diameter;

FIG. 39
a is a schematic illustration of the device of FIG. 33a having a tube configuration and an expanded diameter in accordance with another embodiment of the present invention;

FIG. 39
b is a schematic illustration of the device of FIG. 39a having a minimized diameter;

FIGS. 40
a-40d are schematic illustrations of the device of FIG. 33a depicting an expandable portion in accordance with various embodiments of the present invention;

FIG. 41
a is a schematic illustration of a mounting unit with a catheter placed therein;

FIG. 41
b is a schematic illustration of the mounting unit of FIG. 41a and further including the device of FIG. 33a mounted thereon;

FIG. 42
a is a schematic illustration of a guiding catheter to be used for introduction of the catheter and the device of the present invention into a vessel;

FIG. 42
b is a schematic illustration of the guiding catheter of FIG. 42a with the catheter and device placed therein; and

FIGS. 43
a-43e are schematic illustrations of a method of positioning of a catheter in an ostial lesion in accordance with embodiments of the present invention.

It will be appreciated that for simplicity and clarity of illustration, elements shown in the drawings have not necessarily been drawn accurately or to scale. For example, the dimensions of some of the elements may be exaggerated relative to other elements for clarity or several physical components may be included in one functional block or element. Further, where considered appropriate, reference numerals may be repeated among the drawings to indicate corresponding or analogous elements. Moreover, some of the blocks depicted in the drawings may be combined into a single function.

DESCRIPTION OF THE PREFERRED EMBODIMENTS

In the following detailed description, numerous specific details are set forth in order to provide a thorough understanding of the present invention. It will be understood by those of ordinary skill in the art that the present invention may be practiced without these specific details. In other instances, well-known methods, procedures, components and structures may not have been described in detail so as not to obscure the present invention.

Embodiments of the present invention are directed to catheter systems and methods. Specifically, the present invention can be positioned in a vessel with rotational and translational alignment. In addition to providing substantially predictable alignment, the devices and systems of the present invention have small outer diameters as compared with prior art systems, particularly ones which are suitable for treating a bifurcation, and reduce the possibility of wire entanglement.

Embodiments of the present invention are directed to a positioning device for treatment of an ostial lesion. The principles and operation of a system and methods according to the present invention may be better understood with reference to the drawings and accompanying descriptions.

Before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of the components set forth in the following description or illustrated in the drawings. The invention is capable of other embodiments or of being practiced or carried out in various ways. Also, it is to be understood that the phraseology and terminology employed herein is for the purpose of description and should not be regarded as limiting.

Reference is now made to FIG. 1, which is an illustration of a vessel bifurcation with plaque buildup. A main vessel 1 and a branch vessel 2 meet at a bifurcation point 3. A buildup of plaque 4 may be found anywhere within the vessels, but if there is plaque buildup located at or close to bifurcation point 3, as shown in FIG. 1, the location presents a specific challenge with regard to accurate stent placement. Stents placed at bifurcations are typically deployed either slightly proximal or slightly distal to the bifurcation point, which can lead to stent jailing and/or insufficient coverage.

Reference is now made to FIG. 2, which is an illustration of a prior art bifurcation stent delivery system 5. System 5 includes a catheter 6 having a stent 7 with a dedicated side hole 8. A main guidewire 9 is positioned in main vessel 1 and passed through a main guidewire lumen in catheter 6. A side branch guidewire 11 is positioned within a second guidewire lumen, through side hole 8, and into branch vessel 2. As shown in FIG. 1, there is a tendency for system 5 to overshoot bifurcation point 3 during placement. Additionally, prior art bifurcation stent systems are generally large in diameter due to the presence of two guidewire lumens—one for main guidewire 9 and one for branch guidewire 11. Furthermore, the two wires often become entangled with one another, causing a failure in delivery and/or removal of the system.

The present invention seeks to address the limitations of prior art systems, by providing substantially predictable positioning and alignment, both translationally and rotationally within the vessel, while retaining a small profile and eliminating wire crossing so as to provide ease of delivery. Several different embodiments of the invention provide solutions for different types of lesions, as will be described in further detail hereinbelow.

Lesion Type 1, Type 2 and Type 4:

In a first embodiment, a stent delivery system 10 is designed to be delivered at a Type 1, Type 2 or Type 4 bifurcation lesion, as illustrated in FIGS. 29a, 29b and 29d, respectively. In these types of bifurcation lesions, the plaque 4 is at least partially located within the main vessel in the vicinity of bifurcation point 3, and may also be located within branch vessel 2.

Reference is now made to FIG. 3 and FIGS. 4a-d, which are illustrations of a bifurcation stent delivery system 10, shown with and without a stent respectively. System 10 includes a main elongated element 16, and an auxiliary elongated element 34 aligned with main elongated element 16. In a preferred embodiment, auxiliary elongated element 34 is positioned within main elongated element 16 proximal to an exit point 37 and alongside main elongated element 16 distal to exit point 37, as depicted in FIG. 3. In an alternative embodiment, auxiliary elongated element 34 is positioned alongside main elongated element 16, as will be described hereinbelow with reference to FIG. 8.

In a preferred embodiment, main elongated element 16 is a catheter 18 having a distal end 20 and a proximal end 22. A balloon 24 is positioned on distal end 20 of catheter 18. Catheter 18 includes a hypotube 25 running along a proximal portion of the catheter, and an inflation lumen within hypotube 25 in communication with balloon 24. Hypotube 25 is comprised of stainless steel, or any other suitable material which provides rigidity. At a distal portion of catheter 18, a polymer jacket replaces hypotube 25, providing flexibility for navigation through the vessel. The inflation lumen continues to run through the polymer jacket portion of catheter 18 and into balloon 24. The inflation lumen is designed for introducing a fluid, preferably a liquid, into balloon 24 for inflation of balloon 24 at the appropriate location. A port for inflation is positioned at proximal end 22, in a configuration which is well known in the art. Catheter 18 shown in FIGS. 3 and 4a-d may be any commercially available balloon catheter. Optionally, a torquer device may be introduced to proximal end 22 for improving torqueability. Such torquer devices are well known in the art, and may be purchased, for example from Qosina Corp. (Edgewood, N.Y., USA, catalog part number 97333).

In an exemplary preferred embodiment, balloon 24 is a fixed wire balloon and as such, includes a fixed wire 26 attached to a distal end of balloon 24 at a bonding area 28. A core wire 30 (or skeleton) runs along the interior of balloon 24 to provide rigidity to the flexible portion of catheter 18. In a preferred embodiment, core wire 30 is a continuation of fixed wire 26. It is a particular feature of the present invention that core wire 30 is connected at a proximal end thereof to hypotube 25, at a distal end thereof to the distal end of balloon 24, and in at least one other location in between. Referring again to FIGS. 4a and 4c, core wire 30 is bonded to catheter 18 at an area of cross section B-B, where side branch lumen 36 exits catheter 18. Furthermore, core wire 30 is relatively thick as compared to a filament which is present within commercially available fixed wire balloons. Such filaments are typically within a range of 0.005 to 0.009 inches (most commonly around 0.007 inches), while the core wire 30 of the present invention is in a range of 0.009-0.012 inches (most preferably around 0.01 inches). This thickness, along with additional bonding of core wire 30 to catheter 18, provides rigidity along an entire length of catheter 18. This rigidity allows transmission of torque forces from proximal end 22 to distal end 20 of catheter 18, and minimal loss of such forces due to bending or twisting of the polymer jacket, thus providing enhanced torqueability of the system. Furthermore, the rigidity provided by core wire 30 and the features described above provide enhanced pushing capability of the system of the present invention, by preventing absorption of pushing forces by the polymer jacket or by other relatively compliant portions of system 10.

System 10 includes a stent 12 positioned on main elongated element 16, the stent 12 having a side opening 14. In one embodiment, side opening 14 is a dedicated side opening, and in another embodiment, side opening 14 is any opening within the structure of stent 12. For example, a stent having a diamond configuration of struts might not require a dedicated side opening, as any cell may be used to access the branch vessel. In a preferred embodiment, auxiliary elongated element 34 is a side branch lumen 36 for placement of a side branch guidewire therethrough. Side branch lumen 36 has a distal end 40 and a proximal end 42 and is attached to catheter 18 at proximal end 42 and unattached to catheter 18 at distal end 40. The point at which the detachment between main and auxiliary elongated elements (catheter 18 and side branch lumen 36 in the present embodiment) occurs is defined as a crotch point 44. In an alternative embodiment, side branch lumen 36 is unattached to catheter 18 both proximal and distal to crotch point 44, and is attached to catheter 18 only at crotch point 44. Core wire 30 further includes fluorescent markers 32 which can be visualized during a procedure under fluorescence. In a preferred embodiment, markers 32 are aligned with each end of stent 12 and with crotch point 44, forming a row of markers. In an exemplary preferred embodiment, an additional marker is included at distal end 40 of side branch lumen 36. This configuration provides a view of the rotational alignment of system 10 within the vessel. A discussion of marker configuration and alignment is discussed in more detail hereinbelow with respect to FIGS. 27a-d and 28. In alternative embodiments, any configuration of markers which would enable viewing of key locations of system 10 can be used.

Crotch point 44 is preferably located close to distal end 40 of side branch lumen 36. It should be noted that the depiction of crotch points in the figures is for indication purposes only, and that crotch points may not include an actual connecting element as shown. The length of the unattached portion is preferably less than 1 mm. In an exemplary preferred embodiment, the length of the unattached portion is approximately 0 mm, i.e. the distal end 40 of side branch lumen 36 is at crotch point 44. It should be noted that in this embodiment, a guidewire within side branch lumen 36 is configured to enter a side branch vessel, as will be described hereinbelow with reference to FIG. 5. This guidewire positioned within side branch lumen 36, and main elongated element 16 form crotch point 44. In an alternative embodiment, the length of the unattached portion is approximately 1-5 mm, or more preferably approximately 2 mm. Side branch lumen 36 may be as long or as short as necessary, both proximally and distally. In a preferred embodiment, the portion of side branch lumen 36 which is proximal to crotch point 44 is approximately 10-30 mm, and in an exemplary preferred embodiment is approximately 25 mm. By extending side branch lumen 36 proximally along at least a portion of hypotube 25, the rigidity of system 10 is increased, thus providing ease of rotation within the vessel. In an alternative embodiment, the portion of side branch lumen 36 which is proximal to crotch point 44 is approximately 5-15 mm.

Cross-sectional views along lines A-A, B-B and C-C are depicted in FIGS. 4b, 4c and 4d, respectively. As shown in FIG. 4b, at a proximal location, side branch lumen 36 is located within catheter 18. Core wire 30 is in the center, and side branch lumen 36 is between core wire 30 and the edge of catheter 18. As shown in FIG. 4c, at exit point 37, side branch lumen 36 is bonded to catheter 18. Distal to exit point 37, side branch lumen 36 is outside and adjacent to balloon 24, as shown in FIG. 4d.

Reference is now made to FIG. 5, which is an illustration of system 10 positioned at a bifurcation. Crotch point 44 is a key element in positioning of stent 12 within the vessel. With catheter 18 in main vessel 1 and a side branch guidewire 38 within side branch lumen 36 positioned in branch vessel 2, system 10 cannot be advanced beyond the point at which crotch point 44 reaches bifurcation point 3. Thus, system 10 is substantially predictably aligned, and overshooting is prevented. Side branch guidewire 38 is chosen to have optimal stiffness. In a preferred embodiment, guidewire 38 has an intermediate stiffness, such that it is stiff enough to guide system 10 and to prevent system 10 from advancing beyond crotch point 44, but not too stiff so as to risk puncturing the vessel.

In an exemplary preferred embodiment, a method for introducing system 10 is as follows. First, a side branch guidewire 38 is positioned within branch vessel 2. A proximal end of side branch guidewire 38 is introduced into distal end 40 of side branch lumen 36. With side branch guidewire 38 positioned within side branch lumen 36, system 10 is advanced through main vessel 1. Fixed wire 26 provides guidance as advancement occurs. In an alternative embodiment, side branch guidewire 38 is not introduced initially, and system 10 is advanced using only fixed wire 26 as a guide. In this embodiment, side branch guidewire 38 is initially backloaded into side branch lumen 36 and remains within side branch lumen 36 as system 10 is advanced through main vessel 1. In either case, system 10 is free to rotate without risk of entanglement. When crotch point 44 reaches bifurcation point 3, advancement of system 10 automatically stops. At this point, system 10 is in place, with side branch guidewire 38 in branch vessel 2, and stent 12 in a correct position both translationally and rotationally. Balloon 24 is then inflated, thus deploying stent 12 within the vessel. Thus, the exact location of crotch point 44 predetermines accuracy of positioning. After deployment, system 10 is removed from branch vessel 2. A particular feature of the invention as described is the ability to provide rapid exchange of catheters via branch guidewire 38, if necessary.

It should be apparent that the specific features of the present invention allow for accurate positioning in both the rotational and the translational direction, while providing a small outer diameter overall. In a preferred embodiment, the overall outer diameter is 0.5-1.5 mm. Specifically, by attaching side branch lumen 36 directly to balloon 24, for example, and predetermining the location of crotch point 44, side branch lumen 36 acts as a guide in the translational plane. The use of a fixed wire provides torqueability and ease of rotation, particularly since there is only one guidewire present (i.e. the branch guidewire). The presence of a bonded, relatively thick core wire 30 provides rigidity and ease of transmission of torque and pushing forces. The configuration of side branch lumen 36 wherein a distal end 40 thereof is unattached to main elongated element 16, or wherein a guidewire placed therethrough is unattached to main elongated element 16 allows for initial entry of side branch lumen 36 into branch vessel 2. These aspects allow for substantially predictable rotation of the system and substantially predictable rotational positioning, without wire entanglement.

In one embodiment, the system 10 illustrated in FIGS. 3, 4a-d and 5 is configured for use in treating an intracranial aneurysm. Current methods for treating such aneurysms include the use of self-expanding stents such as, for example, the Neuroform™ stents manufactured by Boston Scientific Corp. (MA, USA). Specifically, such stents are presented to the site of the aneurysm and deployed, after which a standard microcatheter is introducible through openings of the deployed stent. An embolic coil is introduced into the aneurysm through the microcatheter to plug the site of the aneurysm. Self expanding stents are generally used due to their low profile and maneuverability, features which are crucial for small vessels associated with intracranial aneurysms. However, they are prone to positioning problems and are difficult to anchor in place during deployment. A system such as the one described in preferred embodiments of the present invention can be used in place of self expanding stents for treatment of aneurysms, and provide both the benefits of small profile and maneuverability as well as better positioning and anchoring.

Reference is now made to FIGS. 30A-30E, which are illustrations of steps of a method for treating an intracranial aneurysm in accordance with one embodiment of the present invention. As shown in FIG. 30A, system 10 is introduced into a vessel 200 with an aneurysm 202, and positioned such that side opening 14 of stent 12 is situated at the site of the aneurysm, as shown in FIG. 30B. Alternatively, a stent without a side opening may be used. Positioning may be done by using markers and/or by the introduction of guidewire 38 through side branch lumen 36. Once the system is in place, stent 12 is deployed, as shown in FIG. 30C. Catheter 18 is removed, leaving stent 12 and guidewire 38 in place at the site of the aneurysm, as shown in FIG. 30D. As shown in FIG. 30E, a standard microcatheter 204 is then introduced over guidewire 38 through side opening 14 and into the area of the aneurysm, through which an embolic coil 206 may be delivered to the site.

Reference is now made to FIG. 6, which is an illustration of system 10 in accordance with an alternative embodiment of the present invention. As shown in FIG. 6, system 10 further includes a distal connecting element 46, attached to a distal end of balloon 24. In a preferred embodiment, distal connecting element 46 is attached at bonding area 28 of balloon 24. In an alternative embodiment, distal connecting element 46 is attached at any other location on balloon 24 which is distal to side branch lumen 36. Distal connecting element 46 is configured to hold side branch guidewire 38 in place until system 10 is in the vicinity of bifurcation 3. This prevents side branch guidewire 38 from moving around within the vessel during delivery of system 10, possibly causing damage. Once system 10 is within the general vicinity of bifurcation 3, side branch guidewire 38 is pulled proximally and released from distal connecting element 46, after which it is advanced into branch vessel 2. System 10 is then advanced until crotch point 44 prevents further advancement, balloon 24 is inflated, and stent 12 is deployed.

Reference is now made to FIG. 7, which is an illustration of system 10 in accordance with yet another embodiment of the present invention. As shown in FIG. 7, side branch lumen 36 is located internally within balloon 24, and includes an exit point 37 at a location along balloon 24. The location of exit point 37 with respect to stent 12 defines a crotch point, which coincides with the location of crotch point 44 described in the earlier embodiments, and is functionally equivalent thereto. In one embodiment, side branch lumen 36 ends at crotch point 44. In an alternative embodiment, side branch lumen 36 extends distally beyond crotch point 44.

Reference is now made to FIG. 8, which is an illustration of system 10 in accordance with yet another embodiment of the present invention. Side branch lumen 36 is located external and adjacent to main elongated element 16. Crotch point 44 is located distal to an attachment point between side branch lumen 36 and balloon 24. The portion of side branch lumen 36 which lies between the attachment point and crotch point 44 may be attached or unattached to balloon 24.

Reference is now made to FIGS. 9a and 9b, which are illustrations of system 10 in accordance with yet another embodiment of the present invention, shown with a stent thereon. In this depiction, side hole 14 is not a dedicated side hole, but rather is any opening within the body of stent 12. It should be noted that this type of stent may be included on any of the embodiments described herein. System 10 includes a main guidewire 39 rather than a fixed wire at the distal end of balloon 24. A main guidewire lumen 50 is located at bonding area 28 of balloon 24. In a preferred embodiment, main guidewire lumen 50 is relatively short, i.e. 1-5 mm. In alternative embodiments, main guidewire lumen 50 extends proximally along a side of balloon 24. In a preferred embodiment, main guidewire 39 is positioned outside of stent 12 so as to avoid wire crossing between main guidewire 39 and side branch guidewire 38, as shown in FIG. 9a. In an alternative embodiment, main guidewire 39 is positioned within stent 12, as shown in FIG. 9b. In a preferred embodiment, main guidewire lumen 50 is positioned on an opposite side from side branch lumen 36, as depicted.

In an alternative embodiment (not shown) of the present invention, system 10 includes a main guidewire lumen in place of a fixed wire, and further includes a crotch point 44 in accordance with the different embodiments described above.

The embodiment shown in FIG. 9b allows for main guidewire 39 to be fixed during insertion and movable after inflation of balloon 24. In one embodiment, main guidewire 39 is fixed during insertion by crimping of a stent thereon. In another embodiment, balloon 24 is formed to hold guidewire 39 therein prior to inflation and to release guidewire 39 following inflation. The configuration of balloon 24 forms a “temporary lumen”, defined as a lumen which is present on balloon 24 only in a deflated state. That is, inflation of balloon 24 causes balloon 24 to unfold, resulting in a disappearance of the temporary lumen and release of guidewire 39. Reference is now made to FIGS. 31A and 31B, which are cross-sectional illustrations of system 10 showing balloon 24 in a deflated state with main guidewire 39 positioned within a temporary lumen 27, in accordance with embodiments of the present invention. As shown in FIG. 31A, balloon 24 is folded in an “S” shape having a containment area 80 in one of the curved portions of the “S” shape. Main guidewire 39 is positioned in containment area 80, while auxiliary elongated element 34 is positioned outside of balloon 24. Stent 12 is positioned around balloon 24, main guidewire 39 and auxiliary side branch lumen 36. In another embodiment, shown in FIG. 31B, balloon 24 is folded in a hooked “Y” shape, wherein the bottom portion of the “Y” shape is curved to form a containment area 82. The portion of the “Y” shape determined by the two arms of the “Y” acts as a secondary containment area 84 for holding side branch lumen 36 therein. Containment area 80 or 82 acts as a temporary lumen 27, at least partially containing main guidewire 39 therein until inflation of balloon 24. Stent 12 is positioned around balloon 24, main guidewire 39 and side branch lumen 36.

In this embodiment, side branch lumen 36 is a guidewire enclosure for placing of a guidewire therethrough. In a preferred embodiment the guidewire enclosure is at least partially attached to the catheter at the crotch point. In a preferred embodiment, the guidewire enclosure is at least partially positioned within the catheter body so as to minimize the outer profile of the catheter. The distal end of the guidewire enclosure can be located at or distal to the attachment point.

In a preferred embodiment, a guidewire lumen 50 is attached to the balloon distal end, and has a length of less than 15 mm. The containment area 80 or 82 forming temporary lumen 27 is preferably longitudinally aligned with the guidewire lumen, such that a distal end of the guidewire is positionable through the guidewire lumen and a portion of the guidewire which is proximal to the distal end of the guidewire is positionable in the temporary lumen 27. In a preferred embodiment, the temporary lumen 27 and the guidewire lumen are on an opposite side from the guidewire enclosure. According to additional features, the guidewire enclosure is at least partially positioned within said catheter body and is attached to the catheter body at a location on the balloon. The location is approximately in a center of the balloon.

During a procedure, the catheter system with guidewire 39 positioned through guidewire lumen 50 and in temporary lumen 27 is introduced into the vessel. Upon inflation of the balloon, guidewire 39 is released from temporary lumen 27, and becomes movable with respect to the catheter. In a preferred embodiment, a housing positioned proximal to a proximal end of temporary lumen 27 holds a portion of guidewire 39 in place. Furthermore, a torquer may be placed at a proximal end of the catheter. The method provides the benefits of a fixed wire, with the additional benefit of a second guidewire positioned in the vessel during the procedure.

Lesion Types 4A and 4B:

In a second embodiment, a stent delivery system 110 is designed to be delivered at a Type 4A or 4B bifurcation lesion as illustrated in FIGS. 29e and 29f. In a Type 4A lesion, plaque 4 is located in branch vessel 2, at or near bifurcation 3. In a Type 4B lesion, plaque 4 is located in main vessel 1 distal to the point of bifurcation 3. One example of such a location is the coronary artery, where blockage of, for example, the left anterior descending (LAD) artery is to be avoided while providing coverage to the plaque within the coronary artery. Other examples include renal arteries, the left main coronary artery, vein grafts, and others.

Reference is now made to FIGS. 11a-c, which are illustrations of different embodiments of a system 110 for delivery of a stent at a Type 4A or Type 4B bifurcation lesion. System 110 may be designed with a fixed wire, as shown in FIG. 11a, as on over-the-wire system, as shown in FIG. 11b, or as a rapid exchange system, as shown in FIG. 11c.

Reference is now made to FIG. 11a, which is an illustration of system 110 designed as a single wire system. System 110 includes a main elongated element 116 and an auxiliary elongated element 134. In a preferred embodiment, main elongated element 116 is a catheter 118. In a preferred embodiment, catheter 118 includes a balloon 124 with a fixed wire 126 at a distal end thereof. A stent 112 is positioned on balloon 124. In a preferred embodiment, auxiliary elongated element 134 is a side branch lumen 136, and is attached to catheter 118 at a crotch point 144. Side branch lumen 136 has a proximal end 142 and a distal end 140. In a preferred embodiment, side branch lumen 136 is positioned within catheter 118 proximally, exits at an exit point 137, and is attached to main elongated element 116 at crotch point 144. The portion of side branch lumen 136 between exit point 137 and crotch point 144 may be attached or unattached. In a preferred embodiment, a distal end of side branch lumen 136 is at crotch point 144, and a guidewire placed therethrough extends distally to provide a stopping point. In an alternative embodiment, the distal end of side branch lumen is located 1-5 mm distal to crotch point 144, and is unattached to the catheter 118 in this location.

In an alternative embodiment, side branch lumen 136 is located external to and positioned alongside catheter 118 proximal to crotch point 144, and is unattached to elongated element 116 distal to crotch point 144. In an alternative embodiment, side branch lumen 136 is unattached to catheter 118 both proximal to and distal to crotch point 144. Crotch point 144 is located at or near a proximal end of stent 112. In a preferred embodiment, crotch point 144 is just proximal to the proximal end of stent 112.

Reference is now made to FIG. 11b, which is an illustration of system 110′ designed as an over-the-wire, double rail system. System 110′ is similar to system 110 shown in FIG. 11a, except that in place of a fixed wire on the distal end of balloon 124′, a main guidewire lumen 125 is present and runs the length of catheter 118′. A main guidewire is positioned through main guidewire lumen 125 for entry into main vessel 1. System 110′ may be introduced to the site via a main guidewire located in main guidewire lumen 125 or via a branch guidewire located in side branch lumen 136′.

Reference is now made to FIG. 11c, which is an illustration of system 110″, designed as a rapid exchange dual wire system. System 110″ is similar to both systems 110 and 110′ depicted in FIGS. 11a and 11c, except that in place of a fixed wire or a main guidewire lumen running the length of catheter 118″, a short main guidewire lumen 127 is present and runs proximally until an exit point 129. These types of systems are well known in the art, and are known to provide ease of catheter exchange. In the present invention, the location of crotch point 144 allows for more accurate placement within the vessel.

Reference is now made to FIG. 12, which is a depiction of system 110 positioned at bifurcation 3 for a Type 4B lesion. A side branch guidewire 138 is introduced into branch vessel 2. System 110 is guided over side branch guidewire 138 and either fixed wire 126 or a main guidewire 139, depending on the type of system, until crotch point 144 of side branch lumen 136 is at bifurcation point 3. In a preferred embodiment, distal end 140 is at crotch point 144, and only guidewire 138 enters branch vessel 2. In an alternative embodiment, side branch lumen 136 extends and into side branch vessel 2. System 110 is slowly advanced until crotch point 144 reaches bifurcation point 3, after which system 110 automatically stops advancing. Balloon 124 is then inflated, deploying stent 112. After deployment, balloon 124 is deflated, and system 110 is removed. For a Type 4A lesion, a similar method would be used, but side branch guidewire 138 would be introduced into main vessel 3, and system 110 would be guided into branch vessel 2.

In an alternative embodiment, system 110 is a catheter system and does not include a stent, as shown in FIG. 32. Crotch point 144 is an attachment point which is located at or near a proximal end of balloon 124, rather than at or near a proximal end of stent 112. More specifically, balloon 124 includes a working length portion 146, a proximal narrowed portion 148, and a distal narrowed portion 149. Working length portion 146 is defined as the portion of balloon 124 with the largest outer diameter, while proximal and distal narrowed portions 148, 149 are the portions of balloon 124 which have a smaller diameter than working length portion 146. In one embodiment, crotch point 144 is proximal to working length portion 146, and in some embodiments is located at a junction where working length portion 146 meets up with proximal narrowed portion 148. Auxiliary elongated element 134 is a guidewire enclosure for placing of a guidewire therethrough. In a preferred embodiment the guidewire enclosure is at least partially attached to the catheter at the crotch point. In a preferred embodiment, the guidewire enclosure is at least partially positioned within the catheter body so as to minimize the outer profile of the catheter. The distal end of the guidewire enclosure can be located at or distal to the attachment point.

A catheter system having a fixed wire balloon and a partially attached guidewire enclosure such as described above may be beneficial in treating both regular lesions and bifurcated lesions. For a non-bifurcated lesion, a guidewire is introduced into the vessel and through the lesion. The catheter is then advanced over the guidewire by introducing a proximal end of the guidewire into the guidewire enclosure of the catheter. The catheter is advanced until it reaches the lesion, and is thus in a position such that the guidewire lies alongside the balloon. Upon inflation of the balloon, the guidewire is compressed into the lesion site, and provides a focused force to enable the user to crack hard lesions at low pressure before the balloon is fully inflated. Doing so allows vessel stretching to occur at a lower strain rate, thus minimizing the trauma associated with balloon dilatation.

The presence of a guidewire enclosure further provides an opportunity to treat lesions located at a bifurcation without reintroduction of the system. After treatment of a lesion in the first vessel, a second vessel which is connected to the first vessel at a bifurcation can be treated using the same guidewire. After treatment of the first lesion, the balloon is deflated, the catheter is retracted along the guidewire, and introduced into the second vessel. The balloon is then inflated so as to compress the lesion in the second vessel.

In an alternative method, the guidewire is introduced into the second vessel, the catheter is advanced over the guidewire past the bifurcation and into the first vessel. The first lesion is then treated by inflating the balloon and compressing the lesion. The balloon is deflated, the catheter is retracted, and introduced into the second vessel such that the guidewire is positioned alongside the balloon. Upon inflation of the balloon, the guidewire is compressed into the lesion site, and provides a focused force to enable the user to crack hard lesions at low pressure before the balloon is fully inflated.

In an alternative embodiment, a stent delivery system 210 is designed to be delivered at a bifurcation lesion such as the one illustrated in FIG. 13, having a main vessel 1 and a branch vessel 2 at an angle with respect to main vessel 1, and wherein plaque 4 is located in branch vessel 2 at an area of a bifurcation 3. In an exemplary preferred embodiment, main vessel 1 is an aorta.

Reference is now made to FIGS. 14a and 14b, which are views of a system 210 in accordance with an embodiment of the present invention. System 210 includes a main elongated element 216 and an auxiliary elongated element 234. In a preferred embodiment, main elongated element 216 is a catheter 218 having a proximal end 222 and a distal end 220. Catheter 218 has a balloon 224 at distal end 220, with a stent 212 positioned thereon. In one embodiment, balloon 224 includes a main guidewire lumen 227. In an alternative embodiment, balloon 224 is a fixed wire balloon, such as described with reference to the first and second embodiments, and shown at least in FIGS. 4a and 11a. In a preferred embodiment, main guidewire lumen 227 extends only partially in the proximal direction along catheter 218 and includes an exit point 229 for rapid exchange. In an alternative embodiment, system 210 is an over-the-wire system and main guidewire lumen 227 extends proximally to the proximal end of catheter 218. In a preferred embodiment, auxiliary elongated element 234 is a positioning system 236, which will be described in further detail hereinbelow.

In a preferred embodiment, positioning system 236 includes a stopper element 250 and an attachment mechanism 252. In a preferred embodiment, stopper element 250 is separate from attachment mechanism 252 and comprises, for example, spring wires, flexible polymers, or any other material which can be extended in a first configuration and which can be folded, sprung or otherwise positioned to act as a stopper in a second configuration. In an alternative embodiment, stopper element 250 is part of attachment mechanism 252, but can also be extended in a first configuration and positioned to act as a stopper in a second configuration. In one preferred embodiment, stopper element 250 is comprised of a shape memory metal such as, for example, Nitinol. In the embodiment described herein, spring wires are used as stopper element 250, which are designed to lay substantially horizontal to catheter 218 in their unextended positions and to coil or spring into a stopper upon release. Attachment mechanism 252 attaches the spring wires to main elongated element 216 to form crotch points 244. In a preferred embodiment, attachment mechanism 252 is a jacket having a proximal end 256 and a distal end 254. Attachment mechanism 252 at least partially encloses stopper element 250 (shown as spring wires), such that a proximal portion of stopper element 250 enclosed by attachment mechanism 252 is relatively straight, and a distal portion of stopper element 250 is unenclosed and able to move freely. Attachment mechanism 252 can comprise any biocompatible material, and is preferably comprised of a polymer. In a preferred embodiment, crotch points 244 are located at a proximal end of balloon 224.

Reference is now made to FIG. 14b, which is a cross-sectional view of system 210 along the lines A-A, in accordance with one embodiment. Catheter 218 has main guidewire lumen 227 for introduction of a main guidewire 239. Surrounding catheter 218 is stopper element 250, which is held in place by attachment mechanism 252.

Various embodiments of the positioning system 236 are further shown and described with respect to FIGS. 33-43, below. These figures illustrate various features of the attachment mechanism and stopper element, which may be interchanged between the various described embodiments. For example, as shown, FIGS. 33-43 illustrate the attachment mechanism integral to the stopper element to form an anchoring portion and expandable portion. However, configurations of the anchoring portion including the wire mesh, coil, double helix, braid, tube, or stent-like configuration may be used independently with the separate spring wires of FIG. 14, described above. Other variations will be apparent to a person of skill in the art given the present disclosure and are within the scope of the present invention.

Reference is now made to FIGS. 15a-b, which are illustrations of system 210 partially enclosed within a holder 254. The purpose of holder 254 is to temporarily hold stopper element 250 in a substantially straight configuration until the area of bifurcation point 3 is reached. In a preferred embodiment, holder 254 is a peel-away device. When holder 254 is in place, stopper element 250 is enclosed and lies approximately along the plane of main elongated element 216. In the embodiment shown in FIGS. 15a and b, stopper elements 250 are straightened in the distal direction, such that they run alongside stent 212. The area proximal to crotch points 244 is shown in cross section in FIG. 15b, and includes a main guidewire lumen 227 within catheter 218, stopper elements 250 enclosed within attachment mechanism 252, and holder 254 surrounding attachment mechanism 252.

Reference is now made to FIGS. 16a-b, which are illustrations of system 210 partially enclosed within holder 254, in accordance with another embodiment of the present invention. In the illustration shown in FIGS. 16a and b, stopper elements 250 are bent in a proximal direction, with holder 254 surrounding stopper elements 250 and holding them in place. That is, stopper elements 250 are folded over attachment mechanism 252. The area proximal to crotch points 244 is shown in cross section in FIG. 16b, and includes a main guidewire lumen 227 within catheter 218, stopper elements 250 enclosed both within and outside of attachment mechanism 252, and holder 254 surrounding attachment mechanism 252 and stopper elements 250.

Reference is now made to FIG. 17, which is a depiction of system 210 within a guiding catheter 260. Guiding catheter 260 includes a proximal end 262, through which system 210 is introduced, and a distal end 264, which is open to a vessel. As system 210 is guided into proximal end 262 of guiding catheter 260, holder 254 is removed, since stopper element 250 will remain in place within guiding catheter 260. In a preferred embodiment, holder 254 is a peel-away system, wherein the outer walls may be peeled away and removed from the system while system 210 is being introduced into guiding catheter 260. This introduction is performed outside of the body. In an alternative embodiment, holder 254 is a sheath, which can be pulled back as system 210 is being introduced into guiding catheter 260. Holder 254 can be any device for holding stopper element 250 in place until system 210 is within guiding catheter 260.

Reference is now made to FIGS. 18a and 18b, which are depictions of a method for introducing system 210 to a bifurcation in accordance with an embodiment of the present invention. Guiding catheter 260 with system 210 positioned therein is introduced through main vessel 1 until bifurcation point 3. Distal end 264 of guiding catheter 260 is visualized using methods currently known in the art, such as, for example, fluorescent markers. Once distal end 264 of guiding catheter 260 is at the entrance to branch vessel 2, system 210 is advanced through distal end 264 of guiding catheter 260, as shown in FIG. 18a. As system 210 is advanced, stopper elements 250 are no longer held in place by guiding catheter 260, and will spring or coil into their second configuration, acting as stoppers, as shown in FIG. 18b. System 210 is then advanced until stopper elements 250 prevent system 210 from further advancement, as shown in FIG. 18c. At this point, system 210 is properly positioned, and stent 212 is deployed.

Y-Bifurcation:

In another embodiment, a stent delivery system 310 is designed to be delivered at a bifurcation 3 as illustrated in FIG. 19, having a Y-configuration. Main vessel 1 branches into two branch vessels: a first branch vessel 2 and a second branch vessel 2′, and plaque 4 is located in main and/or branch vessels at the area of bifurcation point 3.

Reference is now made to FIG. 20, which is an illustration of a stent delivery system 310, in accordance with one embodiment of the present invention. System 310 includes a main elongated element 316 and an auxiliary elongated element 334. In a preferred embodiment, main elongated element 316 is a catheter 318. Catheter 318 has a proximal end 322 and a distal end 320. Proximal end 322 includes a hub 321 having a Y-valve for dual inflation. Distal end 320 has two balloons: a proximal balloon 324 and a distal balloon 325. Each of proximal and distal balloons 324 and 325 is in fluid communication with its own inflation channel. An outer inflation channel 335 communicates with proximal balloon 324 and an inner inflation channel 327 communicates with distal balloon 325. Outer inflation channel 335 is coaxial with inner inflation channel 327. Alternatively, outer inflation channel 335 and inner inflation channel 327 are positioned side by side. In either case, balloons 324 and 325 may be inflated separately. In an alternative embodiment, outer inflation channel communicates with distal balloon 325 and inner inflation channel 327 communicates with proximal balloon 324. In a preferred embodiment, distal balloon 325 has a fixed wire 326 at a distal end thereof. In alternative embodiments, system 310 includes a main guidewire lumen or a short external guidewire lumen such as distal connecting element 50 shown in FIG. 6.

In a preferred embodiment, auxiliary elongated element 334 is a side branch lumen 336 having a proximal end 342 and a distal end 340. In a preferred embodiment, side branch lumen 336 is located internally within catheter 318, and exits therefrom at an exit point 337. Distal to exit point 337, side branch lumen 336 is adjacent to proximal balloon 324 and attached thereto at a crotch point 344. In an alternative embodiment, side branch lumen 336 lies alongside proximal balloon 324.

Reference is now made to FIG. 21, which is an illustration of system 310 with stents. In a preferred embodiment, two stents are included, as shown. A proximal stent 312 is positioned on proximal balloon 324, and a distal stent 313 is positioned on distal balloon 325. Each stent may be separately deployed by inflating its corresponding balloon. Proximal stent 312 is positioned such that distal end of side branch lumen 336 is approximately aligned with a distal end of proximal stent 312. The distal edges of side branch lumen 336 and stent 312 form a crotch point 344. In an alternative embodiment, side branch lumen 336 extends distally past crotch point 344. All of the embodiments described earlier in the present application may further be applied here.

In alternative embodiments, system 310 includes one, two or no stents, depending on the application. For example, system 310 may be used for predilatation, with a stent only on proximal balloon 324. Alternatively, a tapered vessel may require two different stent sizes, wherein one stent of a particular size is positioned on distal balloon 325, while another stent of a different size is positioned on proximal balloon 324.

Reference is now made to FIGS. 22a-d, which are illustrations of a method of deploying system 310 within a Y-bifurcation. First, a side branch guidewire 338 is introduced into a first branch vessel 2. A proximal end of side branch guidewire 338 is then placed through a distal end of side branch lumen 336. System 310 is advanced over side branch guidewire 38 through main vessel 1 and into second branch vessel 2′. When crotch point 344 reaches bifurcation 3, system 310 will not be advanceable, and system 310 will be in place, as shown in FIG. 22a. As shown in FIG. 22b, distal balloon 325 is inflated via inner inflation channel 327, deploying distal stent 313 in a branch vessel, just distal to bifurcation point 3. After deployment of distal stent 313, proximal balloon 324 is inflated via outer inflation channel 335, deploying proximal stent 312. An alternate method is depicted in FIG. 22c, wherein proximal stent 312 is deployed first, and then distal stent 313 is deployed. In an alternative embodiment, both stents are deployed simultaneously. The final result with both stents deployed and in position is shown in FIG. 22d.

Reference is now made to FIG. 23, which is an illustration of a tapered balloon system 410, in accordance with an alternative embodiment of the present invention. Similar to the earlier embodiments, tapered balloon system 410 includes a main elongated portion and an auxiliary elongated element 434. In a preferred embodiment, auxiliary elongated element 434 is a side branch lumen. A balloon has a proximal outer diameter and a distal outer diameter which is different from the proximal outer diameter. In a preferred embodiment, the distal outer diameter is smaller than the proximal outer diameter, although the reverse may be provided as well. This type of balloon system may be useful for introduction of a tapered stent into a vessel, so as to avoid over-expansion of a stent within a distal portion of the vessel.

Lesion Type 3:

In another embodiment, a stent delivery system 510 is designed to be delivered at a Type 3 bifurcation lesion as illustrated in FIG. 29c. In a Type 3 lesion, plaque 4 is located in main vessel 1, proximal to the point of bifurcation 3. Stent delivery system 510 is also suitable to be delivered at a lesion in a non-bifurcated vessel, as will be described more fully hereinbelow.

Reference is now made to FIGS. 24a-c, which are illustrations of different embodiments of a system 510 for delivery of a stent at a Type 3 bifurcation lesion. System 510 may be designed with a fixed wire, as shown in FIG. 24a, as on over-the-wire system, as shown in FIG. 24b, or as a rapid exchange system, as shown in FIG. 24c.

Reference is now made to FIG. 24a, which is an illustration of system 510 designed as a single wire system. System 510 includes a main elongated element 516 and an auxiliary elongated element 534. In a preferred embodiment, main elongated element 516 is a catheter 518. In a preferred embodiment, catheter 518 includes a balloon 524 with a fixed wire 526 at a distal end thereof. A stent 512 is positioned on balloon 524. In a preferred embodiment, auxiliary elongated element 534 is a guidewire lumen 536, and is attached to catheter 518 at a crotch point 544. Guidewire lumen 536 has a proximal end 542 and a distal end 540. Crotch point 544 is located at distal end 540. In a preferred embodiment, guidewire lumen 536 is positioned within catheter 518 proximally, exits at an exit point 537, and is attached to main elongated element 516 at crotch point 544. The portion of guidewire lumen 536 between exit point 537 and crotch point 544 may be attached or unattached. In a preferred embodiment, a distal end of guidewire lumen 536 is at crotch point 544, and a guidewire placed therethrough extends distally to provide a stopping point. In an alternative embodiment, the distal end of guidewire lumen is located 1-5 mm distal to crotch point 544, and is unattached to the catheter 518 in this location.

In one embodiment, guidewire lumen 536 is located external to and positioned alongside catheter 518 proximal to crotch point 544, and is unattached to elongated element 516 distal to crotch point 544. In an alternative embodiment, guidewire lumen 536 is unattached to catheter 518 both proximal to and distal to crotch point 544. Crotch point 544 is located at or near a distal end of stent 512. In a preferred embodiment, crotch point 544 is approximately 2-3 mm distal to the distal end of stent 512.

Referring to FIG. 27a, in an exemplary preferred embodiment, balloon 524 is a fixed wire balloon and as such, includes a fixed wire 526 attached to a distal end of balloon 524 at a bonding area 528. A core wire 530 (or skeleton) runs along the interior of balloon 524 to provide rigidity to the flexible portion of catheter 518. Core wire 530 is a continuation of fixed wire 526. It is a particular feature of the present invention that core wire 530 is connected at a proximal end thereof to hypotube 525, at a distal end thereof to the distal end of balloon 524, and in at least one other location in between. Specifically, core wire 530 is bonded to catheter 518 at an area where guidewire lumen 536 exits catheter 518. Furthermore, core wire 530 is relatively thick as compared to a filament which is present within commercially available fixed wire balloons. Such filaments are typically within a range of 0.005 to 0.009 inches (most commonly around 0.007 inches), while the core wire 530 of the present invention is in a range of 0.009-0.012 inches (most preferably around 0.01 inches). This thickness, along with additional bonding of core wire 530 to catheter 518, provides rigidity along an entire length of catheter 518. This rigidity allows transmission of torque forces from proximal end 522 to distal end 520 of catheter 518, thus providing enhanced torqueability of the system. Furthermore, the rigidity provided by core wire 530 and the features described above provide enhanced pushing capability of the system of the present invention, by preventing absorption of pushing forces by the polymer jacket or by other relatively compliant portions of system 510.

Reference is now made to FIG. 24b, which is an illustration of system 510′ designed as an over-the-wire, double rail system. System 510′ is similar to system 510 shown in FIG. 25a, except that in place of a fixed wire on the distal end of balloon 524′, a main guidewire lumen 525 is present and runs the length of catheter 518′. A main guidewire is positioned through main guidewire lumen 525 for entry into main vessel 1. System 510′ may be introduced to the site via a main guidewire located in main guidewire lumen 525 or via a branch guidewire located in guidewire lumen 536′.

Reference is now made to FIG. 24c, which is an illustration of system 510″, designed as a rapid exchange dual wire system. System 510″ is similar to both systems 510 and 510′ depicted in FIGS. 24a and 24c, except that in place of a fixed wire or a main guidewire lumen running the length of catheter 518″, a short main guidewire lumen 527 is present and runs proximally until an exit point 529. In the present invention, the location of crotch point 544 allows for more accurate placement within the vessel.

Reference is now made to FIG. 25, which is a depiction of system 510 positioned at bifurcation 3 for a Type 3 lesion. A side branch guidewire 538 is introduced into branch vessel 2. System 510 is guided over side branch guidewire 538 and either fixed wire 526 or a main guidewire 539, depending on the type of system, until crotch point 544 of guidewire lumen 536 is at bifurcation point 3. In a preferred embodiment, distal end 540 is at crotch point 544, and only guidewire 538 enters branch vessel 2. In an alternative embodiment, guidewire lumen 536 extends into side branch vessel 2. System 510 is slowly advanced until crotch point 544 reaches bifurcation point 3, after which system 510 automatically stops advancing. Balloon 524 is then inflated, deploying stent 512. After deployment, balloon 524 is deflated, and system 510 is removed.

Reference is now made to FIG. 26, which is a depiction of system 510 positioned at a non-bifurcated lesion within a vessel 600. In one embodiment, a guidewire 610 is introduced into vessel 600 and through the lesion. System 510 is guided over guidewire 610 and fixed wire 526 until catheter 518 reaches the lesion site. Location is determined by markers 532, as will be described more fully hereinbelow with respect to FIGS. 27a-d and 28. Balloon 524 is then inflated, deploying stent 512. After deployment, balloon 524 is deflated, and system 510 is removed. By providing a guidewire in the vessel which is held in a guidewire lumen having an exit port distal to the proximal end of catheter 518, a rapid exchange of catheters is possible if necessary. Furthermore, the system can be used in a direct stenting procedure, without the need for predilatation, reducing the invasiveness of the procedure. In an alternative embodiment, guidewire 610 is backloaded and housed in guidewire lumen 536, and system 510 is introduced into the vessel guided by fixed wire 526. System 510 is suitable for crossing the lesion on its own due to the rigidity provided by core wire 530. Once system 510 is in place, guidewire 610 is advanced so that a backup wire is present at and distal to the lesion (for rapid exchange capabilities, for example). Balloon 524 is then inflated, deploying stent 512. There are several advantages in using system 510 as a regular non-bifurcation stent delivery system, over the typical delivery systems currently available. It is widely recognized that rapid exchange has certain advantages, including ease of delivery and ease of interchanging catheters if necessary. However, the presence of a bonded, relatively thick core wire allows for greater ease of rotation and transmission of torque forces without increasing overall diameter, which is advantageous during delivery of the system. Furthermore, in a direct stenting procedure, either guidewire 610 or fixed wire 526 is suitable for crossing the lesion. With fixed wire 526 crossing the lesion, stent 512 is automatically in place.

Reference is now made to FIGS. 27a-d, which are illustrations of a marker configuration, in accordance with a preferred embodiment. As shown in FIG. 27a, a first marker 630, a second marker 632 and a third marker 634 are included on core wire 30, and are aligned with proximal and distal ends of stent 12 and with crotch point 44, respectively. A fourth marker 636 is positioned at crotch point 44, thus forming a triangle with first and second markers 630 and 632. As shown in FIG. 27b, when system 10 is in position, the relative locations of the three markers are consistent with the original configuration. That is, first, second and third markers 630, 632 and 634 are aligned, and fourth marker 636 is off to one side. As shown in FIG. 27c, when system 10 is rotated 90 degrees, all four markers are relatively in the same line. As shown in FIG. 27d, when system 10 is rotated 180 degrees, fourth marker 636 is on the other side of first, second and third markers 630, 632 and 634. In this way, it is possible to visualize the rotational alignment of system 10 on a two-dimensional viewing screen. In addition, markers 634 and/or 636 may be configured in a triangle or pointing shape, as depicted in FIG. 28, pointing toward the branch access. This also provides additional confirmation of correct positioning. Thus, proper alignment at a bifurcation is ascertained when all the markers are correctly positioned with respect to one another, and when the pointing shaped marker points toward the branch.

It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination.

Reference is now made to FIG. 33a, which is a schematic illustration of a device 236′ for positioning of a catheter in an ostial lesion. Device 236′ has a proximal end 256′ and a distal end 254′, and includes an anchoring portion 252′ and an expandable portion 3318. Anchoring portion 252′ is configured to surround a catheter, which may be any available catheter off the shelf, and to be anchored to a shaft of the catheter. In some embodiments, anchoring portion 252′ has a thickness of 0.002-0.050 inches and more preferably has a thickness in a range of 0.002-0.010 inches. The relatively low thickness is designed to keep the overall profile low, even when device 236′ is placed on the catheter shaft. A length of anchoring portion 252′ may vary from 1-10 cm, and more preferably from 3-5 cm. Referring to FIG. 33b, which is a cross-sectional view of device 236′ along lines A-A, anchoring portion 252′ has a first diameter D₁prior to anchoring. Expandable portion 3318 is in some embodiments comprised of extension elements 250′ which are pre-shaped to extend outwardly from anchoring portion 252′, but which may be forcibly folded back in the direction of proximal end 256′ during delivery. It is a feature of the present invention that extension elements 250′ are configured in such a way so as to avoid entanglements with a stent positioned on the catheter. In embodiments of the present invention, extension elements 250′ are 5-10 mm in length. Expandable portion 3318 is configured such that it is immovable with respect to the anchoring portion along the longitudinal axis. This may be accomplished by manufacturing anchoring portion 252′ and expandable portion 3318 from one material. Alternatively, expandable portion 3318 may be comprised of a different material than anchoring portion 252′, and may be attached thereto via any suitable attachment means.

Reference is now made to FIGS. 34a and 34b, which are a schematic illustration of device 236′ positioned on a catheter 218 and a cross-sectional view of device 236′ positioned on catheter 218 along lines B-B, respectively. Catheter 218 has a proximal end 222, a distal end 220 and a shaft 3430 running along its length. A treatment device 3450 is positioned at distal end 220. In some embodiments, treatment device 3450 is a balloon 224 positioned at distal end 220 and may optionally include a stent 212 positioned on balloon 224, as shown in FIG. 34a. In other embodiments, treatment device 3450 is a self-expanding stent, a drug delivery mechanism, a cauterizing tip, or any other treatment device which can be used with a catheter. A guidewire lumen 227 runs through balloon 224 and at least a portion of shaft 3430. Catheter 218 may be any catheter, such as an over-the-wire catheter, a rapid exchange catheter, or variations thereof. Alternatively, catheter 218 may be a catheter without a balloon or a stent, such as a laser catheter or any other catheter which may be used for treating a vessel. Device 236′ is designed to be positionable on and anchored to any catheter or delivery system having a shaft. The catheter design depicted in the present application is for description purposes only and should not be regarded as limiting.

Device 236′ is positionable on shaft 3430 of catheter 218, and can be anchored thereto, as shown in FIG. 34a. When anchored onto shaft 3430, anchoring portion 252′ has a second diameter D₂as shown in FIG. 34b, wherein second diameter D₂is smaller than first diameter D₁. Device 236′ is positioned proximal to balloon 224 of catheter 218, such that distal end 254′ including expandable portion 3318 in its extended or folded back position also remains proximal to balloon 224. The exact position of device 236′ on shaft 3430 may be determined just prior to insertion of catheter 218 in a body, as will be described in further detail hereinbelow. It is a particular feature of the present invention that once device 236′ is anchored onto shaft 3430, it remains on shaft 3430 for the entire duration of the procedure. Thus, when catheter 218 is removed from the body, device 236′ is removed as well.

Anchoring portion 252′ may be of various shapes and configurations. Reference is now made to FIGS. 35a and 35b, which are schematic illustrations of device 236′ showing anchoring portion 252′ comprised of a double helix, in an enlarged (pre-anchored) and minimized (anchored) state, respectively. As shown in FIG. 35a, two strands of wire 3520 may be shaped in a double helix formation (similar to a DNA structure), wherein each wire 3520 crosses over the other and both wires 3520 are configured to surround shaft 3430 of catheter 218. Proximal ends 3521 of wires 3520 may be pulled back proximally, causing anchoring portion 252′ to contract to a minimized diameter and to contact shaft 3430 of catheter 218. This contracted state provides anchoring of anchoring portion 252′ to shaft 3430. In some embodiments, a sticky coating is applied to a portion of wires 3520 to ensure that anchoring is stable. Extension elements 250′ of expandable portion 3318 are formed from extensions of wires 3520, and may be pre-formed in a bent configuration at an angle to a longitudinal axis 3517 of anchoring portion 252′. In some embodiments, the angle between extension elements 250′ and longitudinal axis 3517 of anchoring portion 252′ is approximately 90 degrees. In other embodiments, the angle may vary from 60 degrees to 120 degrees. Although wires of expandable portion 3318 are pre-formed at a particular angle, they may be forcibly folded back, for example, in a proximal direction so as to be positionable within a guiding catheter or a sheath, as will be described hereinbelow. The two configurations of extension elements 250′—outward at an angle or folded proximally back—both ensure that extension elements 250′ will not become entangled with stent 212.

Reference is now made to FIGS. 36a and 36b, which are schematic illustrations of device 236′ showing anchoring portion 252′ comprised of a stent-like configuration, in an enlarged (pre-anchored) and minimized (anchored) state, respectively. As shown in FIG. 36a, a wire 3520 may be shaped in a stent-like configuration, having struts 3613 and connecting elements 3615 forming a tube-like structure for example. It should be readily apparent that any stent or mesh-like configuration may be used. Anchoring portion 252′ may be crimped onto shaft 3430 of catheter 218, as is commonly done to actual stents when positioned on balloons. In the crimped, contracted state, anchoring portion 252′ is anchored to shaft 3430. In some embodiments, a sticky coating is applied to an internal portion of wires 3520 to ensure that anchoring is stable. Extension elements 250′ of expandable portion 3318 are comprised of extensions of wires 3520, and may be pre-formed in a bent configuration at an angle to longitudinal axis 3517 of anchoring portion 252′. In some embodiments, the angle between expandable portion and longitudinal axis 3517 of anchoring portion 252′ is approximately 90 degrees. In other embodiments, the angle may vary from 60 degrees to 120 degrees. Although wires of expandable portion 3318 are pre-formed at a particular angle, they may be forcibly folded back, for example, in a proximal direction so as to be positionable within a guiding catheter or a sheath, as will be described hereinbelow. The two configurations of extension elements 250′—outward at an angle or folded proximally back—both ensure that extension elements 250′ will not become entangled with stent 212.

Reference is now made to FIGS. 37a and 37b, which are schematic illustrations of device 236′ showing anchoring portion 252′ in a braided configuration, in an enlarged (pre-anchored) and minimized (anchored) state, respectively. As shown in FIG. 37a, a series of strips may be shaped in a braided or woven configuration, wherein a first set of strips 3723 passes over and under a second set of strips 3725, and the second set of strips 3725 passes over and under the first set of strips 3723. This configuration may work similar to a Chinese finger trap, wherein upon pulling the ends outwardly, the diameter is reduced and anything caught in between is locked in. Thus, anchoring portion 252′ may be anchored onto shaft 3430 of catheter 218, by pulling one or both ends of anchoring portion outwardly after placement around shaft 3430. In some embodiments, a sticky coating is applied to an internal portion of strips 3723, 3725 to ensure that anchoring is stable. Extension elements 250′ of expandable portion 3318 are formed from extensions of strips 3723, 3725, and may be pre-formed in a bent configuration at an angle to longitudinal axis 3517 of anchoring portion 252′. In some embodiments, the angle between expandable portion and longitudinal axis 3517 of anchoring portion 252′ is approximately 90 degrees. In other embodiments, the angle may vary from 60 degrees to 120 degrees. Although wires of expandable portion 3318 are pre-formed at a particular angle, they may be forcibly folded back, for example, in a proximal direction so as to be positionable within a guiding catheter or a sheath, as will be described hereinbelow. The two configurations of extension elements 250′—outward at an angle or folded proximally back—both ensure that extension elements 250′ will not become entangled with stent 212.

Reference is now made to FIGS. 38a and 38b, which are schematic illustrations of device 236′ showing anchoring portion 252′ comprised of a coil configuration, in an enlarged (pre-anchored) and minimized (anchored) state, respectively. As shown in FIG. 38a, a wire 3827 is shaped into a coil configured to wrap around shaft 3430. Anchoring portion 252′ may be anchored onto shaft 3430 of catheter 218, by pulling a proximal end of wire 3827 proximally, thus reducing the diameter of anchoring portion 252′ and causing the coil to contact shaft 3430. In some embodiments, a sticky coating is applied to a portion of wire 3827 to ensure that anchoring is stable. Extension elements 250′ of expandable portion 3318 are formed from an extension of wire 3827 which may be split into one, two, three or more individual wire portions. Wires of expandable portion 3318 may be pre-formed in a bent configuration at an angle to longitudinal axis 3517 of anchoring portion 252′. In some embodiments, the angle between expandable portion and longitudinal axis 3517 of anchoring portion 252′ is approximately 90 degrees. In other embodiments, the angle may vary from 60 degrees to 120 degrees. Although wires of expandable portion 3318 are pre-formed at a particular angle, they may be forcibly folded back, for example, in a proximal direction so as to be positionable within a guiding catheter or a sheath, as will be described hereinbelow. The two configurations of extension elements 250′—outward at an angle or folded proximally back—both ensure that extension elements 250′ will not become entangled with stent 212.

Reference is now made to FIGS. 39a and 39b, which are schematic illustrations of device 236′ showing anchoring portion 252′ comprised of a tube, in an enlarged (pre-anchored) and minimized (anchored) state, respectively. As shown in FIG. 39a, a tube 3935 has a seam 3929 which connects a first edge 3931 and a second edge 3933. In some embodiments, first edge 3931 and second edge 3933 are not connected to each other. Anchoring portion 252′ may be anchored onto shaft 3430 of catheter 218, by folding second edge 3933 over first edge 3931 as shown in FIG. 39b, or vice versa. A locking mechanism locks the overlapping positioning of first and second edges 3931 and 3933. The locking mechanism may be, for example, a glue. Alternatively, the locking mechanism may be a clam shell or any other method of attaching one side of a tube to another. In some embodiments, a sticky coating is applied to an inner portion of tube 3935 to ensure that anchoring is stable. Extension elements 250′ of expandable portion 3318 are comprised of portions extending from tube 3935, and may be pre-formed in a bent configuration at an angle to longitudinal axis 3517 of anchoring portion 252′. In some embodiments, the angle between expandable portion and longitudinal axis 3517 of anchoring portion 252′ is approximately 90 degrees. In other embodiments, the angle may vary from 60 degrees to 120 degrees. Although wires of expandable portion 3318 are pre-formed at a particular angle, they may be forcibly folded back, for example, in a proximal direction so as to be positionable within a guiding catheter or a sheath, as will be described hereinbelow. The two configurations of extension elements 250′—outward at an angle or folded proximally back—both ensure that extension elements 250′ will not become entangled with stent 212.

Reference is now made to FIGS. 40a-40d, which are schematic illustrations showing distal end 254′ of device 236′, depicting expandable portion 3318 in accordance with several additional embodiments of the present invention. These depictions are exemplary and should not be regarded as limiting. In a first embodiment, as shown in FIG. 40a, two extension portions 250″ similar to extension elements 250′ of FIG. 33a are positioned at distal end 254′, and are connected to each other via a connecting element 250″. In another embodiment, as shown in FIG. 40b, connecting element 250′″ forms a complete circle, wherein expandable portion 3318 may include two or more extension portions 250″, and wherein all of extension portions 250″ are connected to each other via connecting element 250″′. In another embodiment, shown in FIG. 40c, connecting element 250″′ forms a spiral configuration. In yet another embodiment, shown in FIG. 40d, multiple extension elements 250′ are used. The number of extension elements 250′ may vary from 2 to any number depending on the dimensions of extension elements 250′. It should be readily apparent that many other configurations are possible.

Reference is now made to FIGS. 41a and 41b, which are schematic illustrations of a mounting unit 4142 used for mounting device 236′ onto catheter 218, which may include any catheter off the shelf. Mounting unit 4142 includes a transparent box 4144 having an access port 4146 and measurement units 4148 included thereon. Mounting unit 4142 is comprised of a material which can be sterilized, such that the entire mounting procedure may be performed under sterile conditions. Catheter 218 is placed through access port 4146 and into box 4144, as shown in FIG. 41a. Device 236′ is then introduced through access port 4146, and positioned on shaft 3430 in accordance with measurements determined from measurement units 4148. Thus, a physician may decide on a case-by-case basis how far proximally or distally to position device 236′ with respect to treatment device 3450. This decision may be based on anatomical considerations, or there may be standard measurements which can be used. In some embodiments, device 236′ is positioned just proximal to treatment device 3450. In other embodiments, device 236′ is positioned several millimeters proximal to treatment device 3450. Any position may be chosen. Once the optimal position is determined, device 236′ is anchored onto shaft 3430 in accordance with the methods described above.

In embodiments of the present invention, catheter 218 with device 236′ anchored thereon is introduced into the vessel using a guiding catheter 4240, as shown in FIGS. 42a and 42b. A standard guiding catheter 4240, as shown in FIG. 42a, includes a proximal end 4244, a distal end 4246 and a shaft 4248 connecting proximal end 4244 and distal end 4246. Shaft 4248 defines a lumen 4250 running therethrough, into which may be inserted any items which may be necessary to insert into a vessel, such as a guidewire or a catheter or any other delivery device. A hub 4245 at proximal end 4244 allows for insertion of such items into guiding catheter 4240. As shown in FIG. 42b, when catheter 218 with device 236′ anchored thereon is placed within guiding catheter 4240, extension elements 250′ of expandable portion 3318 are folded back proximally so as to avoid entanglement with stent 212.

Reference is now made to FIGS. 43a-43e, which are schematic illustrations showing a method of using device 236′ in accordance with embodiments of the present invention. Although the method is described with respect to a balloon catheter, it should be readily apparent that any catheter having any type of treatment device thereon may be used. First, a guidewire 4238 is introduced into the vessel through guiding catheter 4240, as shown in FIG. 43a. Next, catheter 218 with device 236′ attached thereto is introduced over guidewire 4238 and through guiding catheter 4240, and guiding catheter 4240 is advanced until it reaches a point proximal to the ostium of the vessel, as shown in FIG. 43b. Catheter 218 with device 236′ anchored thereto is pushed distally, until extension elements 250′ of expandable portion 3318 of device 236′ are released from guiding catheter 4240, as shown in FIG. 43c. Extension elements 250′ assume their pre-shaped configuration, extending outwardly from anchoring portion 252′ and from shaft 3430 of catheter 218. This outward extension causes extension elements 250′ to contact the walls of the main vessel at the ostium, and they may be used as stoppers to prevent catheter 218 from advancing beyond that point, preventing an overly distal positioning of stent 212. Furthermore, they allow the user to advance catheter 218 until it reaches resistance from extension elements 250′ pushing against the walls of the main vessel at the ostium. This prevents stent 212 from being positioned too far proximally and thus jutting out into the main vessel. Once catheter 218 is in place, balloon 224 can be expanded, thus expanding stent 212, as shown in FIG. 43d. The proper positioning by extension elements of expandable portion 3318 of device 236′ allows for the stent to be positioned properly in the vessel. Finally, catheter 218 with device 236′ still attached thereto is pulled proximally into guiding catheter 4240, which is then removed from the vessel, as shown in FIG. 43e. When catheter 218 is pulled proximally into guiding catheter 4240, extension elements 250′ of expandable portion 3318 may be folded forward distally, since it is no longer important to avoid entanglement with stent 212.

Device 236′ may be made from any biocompatible material, such as metals, polymers or combinations thereof. In some embodiments, at least expandable portion 3318 is comprised of a shape-memory alloy or super-elastic material such as Nitinol. While certain features of the present invention have been illustrated and described herein, many modifications, substitutions, changes, and equivalents may occur to those of ordinary skill in the art. For example, a catheter for uses other than expansion of a balloon and/or delivery of a stent may be used with the device of the present invention, such as a catheter for drug delivery at an ostium, for cauterization, or for any other treatment. It is, therefore, to be understood that the appended claims are intended to cover all such modifications and changes as fall within the true spirit of the present invention.

Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. For example, a self-expandable stent may be used in place of a balloon expandable stent, in which case the catheter would not necessarily be a balloon catheter. Accordingly, it is intended to embrace all such alternatives, modifications and variations that fall within the spirit and broad scope of the appended claims. All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention.

Number	Name	Date	Kind
4723948	Clark et al.	Feb 1988	A
4906241	Noddin et al.	Mar 1990	A
4917088	Crittenden	Apr 1990	A
4983167	Sahota	Jan 1991	A
5059178	Ya	Oct 1991	A
5090958	Sahota	Feb 1992	A
5147377	Sahota	Sep 1992	A
5160321	Sahota	Nov 1992	A
5267958	Buchbinder et al.	Dec 1993	A
5267960	Hayman et al.	Dec 1993	A
5320605	Sahota	Jun 1994	A
5342297	Jang	Aug 1994	A
5370617	Sahota	Dec 1994	A
5376074	Buchbinder et al.	Dec 1994	A
5383853	Jung et al.	Jan 1995	A
5395332	Ressemann et al.	Mar 1995	A
5413557	Solar	May 1995	A
5425711	Ressemann et al.	Jun 1995	A
5439445	Kontos	Aug 1995	A
5462530	Jang	Oct 1995	A
5479938	Weier	Jan 1996	A
5520647	Solar	May 1996	A
5522818	Keith et al.	Jun 1996	A
5534007	St. Germain et al.	Jul 1996	A
5569199	Solar	Oct 1996	A
5571087	Ressemann et al.	Nov 1996	A
5591197	Orth et al.	Jan 1997	A
5667521	Keown	Sep 1997	A
5669880	Solar	Sep 1997	A
5681346	Orth et al.	Oct 1997	A
5685847	Barry	Nov 1997	A
5749825	Fischell et al.	May 1998	A
5769821	Abrahamson et al.	Jun 1998	A
5772594	Barrick	Jun 1998	A
5830227	Fischell et al.	Nov 1998	A
5980484	Ressemann et al.	Nov 1999	A
5992000	Humphrey et al.	Nov 1999	A
6007517	Anderson	Dec 1999	A
6048361	Von Oepen	Apr 2000	A
6068610	Ellis et al.	May 2000	A
6082990	Jackson et al.	Jul 2000	A
6110097	Hastings et al.	Aug 2000	A
6165195	Wilson et al.	Dec 2000	A
6210431	Power	Apr 2001	B1
6273879	Keith et al.	Aug 2001	B1
6375660	Fischell et al.	Apr 2002	B1
6394995	Solar et al.	May 2002	B1
6428567	Wilson et al.	Aug 2002	B2
6440097	Kupiecki	Aug 2002	B1
6440161	Madrid et al.	Aug 2002	B1
6458151	Saltiel	Oct 2002	B1
6508836	Wilson et al.	Jan 2003	B2
6520988	Colombo et al.	Feb 2003	B1
6544218	Choi	Apr 2003	B1
6562064	deBeer	May 2003	B1
6579312	Wilson et al.	Jun 2003	B2
6582394	Reiss et al.	Jun 2003	B1
6676691	Hosny	Jan 2004	B1
6676702	Mathis	Jan 2004	B2
6682556	Ischinger	Jan 2004	B1
6692460	Jayaraman	Feb 2004	B1
6692483	Vardi et al.	Feb 2004	B2
6733487	Keith et al.	May 2004	B2
6740104	Solar et al.	May 2004	B1
6780199	Solar et al.	Aug 2004	B2
7300415	McMurtry et al.	Nov 2007	B2
7314480	Eidenschink et al.	Jan 2008	B2
7344557	Yadin	Mar 2008	B2
7399307	Evans et al.	Jul 2008	B2
7455688	Furst et al.	Nov 2008	B2
7655030	Williams et al.	Feb 2010	B2
7753951	Shaked et al.	Jul 2010	B2
7766951	Shaked	Aug 2010	B2
7780715	Shaked et al.	Aug 2010	B2
7901378	Solar et al.	Mar 2011	B2
8070729	Solar et al.	Dec 2011	B2
8262621	Solar et al.	Sep 2012	B2
20010004706	Hojeibane	Jun 2001	A1
20010012927	Mauch	Aug 2001	A1
20010016767	Wilson et al.	Aug 2001	A1
20010016768	Wilson et al.	Aug 2001	A1
20010029396	Wilson et al.	Oct 2001	A1
20010037116	Wilson et al.	Nov 2001	A1
20010037138	Wilson et al.	Nov 2001	A1
20010049548	Vardi et al.	Dec 2001	A1
20010056297	Hojeibane	Dec 2001	A1
20020022874	Wilson	Feb 2002	A1
20020077692	Besselink	Jun 2002	A1
20020091434	Chambers	Jul 2002	A1
20020111675	Wilson	Aug 2002	A1
20020138128	Stiger et al.	Sep 2002	A1
20020147491	Khan et al.	Oct 2002	A1
20020177869	Eidenschink et al.	Nov 2002	A1
20030009209	Hojeibane	Jan 2003	A1
20030028233	Vardi et al.	Feb 2003	A1
20030028235	McIntosh et al.	Feb 2003	A1
20030050688	Fischell et al.	Mar 2003	A1
20030055398	Imran	Mar 2003	A1
20030055483	Gumm	Mar 2003	A1
20030074046	Richter	Apr 2003	A1
20030074047	Richter	Apr 2003	A1
20030114912	Sequin et al.	Jun 2003	A1
20030114920	Caro et al.	Jun 2003	A1
20030125761	Meens et al.	Jul 2003	A1
20030135259	Simso	Jul 2003	A1
20030167083	Lashinski et al.	Sep 2003	A1
20030171642	Schock et al.	Sep 2003	A1
20030181923	Vardi	Sep 2003	A1
20030187494	Loaldi	Oct 2003	A1
20030191436	Horvers	Oct 2003	A1
20040098087	Madrid et al.	May 2004	A1
20040111143	Fischell et al.	Jun 2004	A1
20040122465	McMurtry et al.	Jun 2004	A1
20040138734	Chobotov et al.	Jul 2004	A1
20040172121	Eidenschink et al.	Sep 2004	A1
20040220511	Scott et al.	Nov 2004	A1
20050015135	Shanley	Jan 2005	A1
20050084130	Yamagishi	Apr 2005	A1
20050101968	Dadourian	May 2005	A1
20050137196	Timmer et al.	Jun 2005	A1
20050154440	Limon	Jul 2005	A1
20050209673	Shaked	Sep 2005	A1
20050209677	Shaked	Sep 2005	A1
20050267508	Kato et al.	Dec 2005	A1
20060106448	Shaked	May 2006	A1
20060111689	Rosenschein et al.	May 2006	A1
20060271090	Shaked et al.	Nov 2006	A1
20070173918	Dreher et al.	Jul 2007	A1
20070244431	Limon	Oct 2007	A1
20080033525	Shaked et al.	Feb 2008	A1
20080082050	Solar et al.	Apr 2008	A1
20080228146	Shaked et al.	Sep 2008	A1
20090275920	Solar et al.	Nov 2009	A1
20100234800	Shaked	Sep 2010	A1
20100241212	Shaked et al.	Sep 2010	A1
20100286720	Shaked et al.	Nov 2010	A1
20110034949	Solar et al.	Feb 2011	A1
20110118774	Solar et al.	May 2011	A1

Number	Date	Country
1051984	Oct 2012	CN
0492361	Jul 1992	EP
1931344	Oct 2009	EP
2430990	Mar 2012	EP
2012055719	Mar 2012	JP
5032566	Jul 2012	JP
5137568	Nov 2012	JP
9117714	Nov 1991	WO
9526777	Oct 1995	WO
9808727	Mar 1998	WO
0174273	Oct 2001	WO
0239926	May 2002	WO
02067653	Sep 2002	WO
02067815	Sep 2002	WO
02067816	Sep 2002	WO
03051234	Jun 2003	WO
03061529	Jul 2003	WO
03063729	Aug 2003	WO
03068307	Aug 2003	WO
WO 03063729	Aug 2003	WO
2004008994	Jan 2004	WO
2004103216	Dec 2004	WO
2005084130	Sep 2005	WO
2007039902	Apr 2009	WO
2007132447	Apr 2009	WO

	Number	Date	Country
Parent	11240631	Oct 2005	US
Child	12787067		US

	Number	Date	Country
Parent	11685228	Mar 2007	US
Child	13035670		US
Parent	12787067	May 2010	US
Child	11685228		US
Parent	11070294	Mar 2005	US
Child	11240631		US
Parent	10899034	Jul 2004	US
Child	11070294		US

Positioning device for ostial lesions

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

US

CPC

International Classifications

Term Extension

Abstract

Description

Claims

CROSS-REFERENCE TO RELATED APPLICATIONS

US Referenced Citations (138)

Foreign Referenced Citations (25)

Non-Patent Literature Citations (59)

Related Publications (1)

Provisional Applications (1)

Divisions (1)

Continuation in Parts (4)

Entry
CN 200580011142.7 filed Mar. 3, 2005 Office Action dated Apr. 26, 2010.
EP 05709151.4 filed Mar. 3, 2005 Office Action dated Jul. 8, 2010.
EP 05709151.4 filed Mar. 3, 2005 Search Report dated Jul. 10, 2009.
EP 06796143.3 filed Oct. 3, 2006 Office Action dated Jan. 21, 2011.
EP 06796143.3 filed Oct. 3, 2006 Office Action dated Jan. 7, 2010.
EP 06796143.3 filed Oct. 3, 2006 Search Report dated Sep. 29, 2009.
EP 07736308.3 filed May 10, 2007 Office Action dated Jan. 13, 2010.
EP 07736308.3 filed May 10, 2007 Office Action dated Jan. 20, 2011.
EP 07736308.3 filed May 10, 2007 Search Report dated Nov. 11, 2009.
JP 2007501448 filed Mar. 3, 2005 Office Action dated Jun. 21, 2010.
PCT/IL2005/000258 filed Mar. 3, 2005 International Preliminary Report on Patentability dated Sep. 5, 2006.
PCT/IL2005/000258 filed Mar. 3, 2005 Search Report dated Jan. 3, 2006.
PCT/IL2005/000258 filed Mar. 3, 2005 Written Opinion dated Jan. 3, 2006.
PCT/IL2006/001150 filed Oct. 3, 2006 International Preliminary Report on Patentability dated Mar. 10, 2009.
PCT/IL2006/001150 filed Oct. 3, 2006 Search Report dated Jul. 11, 2008.
PCT/IL2006/001150 filed Oct. 3, 2006 Written Opinion dated Jun. 22, 2008.
PCT/IL2007/000568 filed May 10, 2007 International Preliminary Report on Patentability dated Mar. 31, 2009.
PCT/IL2007/000568 filed May 10, 2007 Search Report dated Oct. 3, 2008.
PCT/IL2007/000568 filed May 10, 2007 Written Opinion dated Apr. 9, 2008.
U.S. Appl. No. 11/240,631, filed Oct. 3, 2005 Final Office Action dated Dec. 16, 2009.
U.S. Appl. No. 11/240,631, filed Oct. 3, 2005 Non-Final Office Action dated Jun. 15, 2009.
U.S. Appl. No. 11/240,631, filed Oct. 3, 2005 Notice of Allowance dated Feb. 26, 2010.
U.S. Appl. No. 11/240,631, filed Oct. 3, 2005 Notice of Allowance dated Jun. 3, 2010.
U.S. Appl. No. 11/431,918, filed May 11, 2006 Advisory Action dated Feb. 25, 2010.
U.S. Appl. No. 11/431,918, filed May 11, 2006 Final Office Action dated Dec. 16, 2009.
U.S. Appl. No. 11/431,918, filed May 11, 2006 Non-Final Office Action dated Jun. 16, 2009.
U.S. Appl. No. 11/431,918, filed May 11, 2006 Notice of Allowance dated Apr. 14, 2010.
U.S. Appl. No. 11/685,228, filed Mar. 13, 2007 Final Office Action dated Mar. 5, 2010.
U.S. Appl. No. 11/685,228, filed Mar. 13, 2007 Final Office Action dated Nov. 29, 2010.
U.S. Appl. No. 11/685,228, filed Mar. 13, 2007 Non-Final Office Action dated May 13, 2009.
U.S. Appl. No. 11/746,682, filed May 10, 2007 Notice of Allowance dated Sep. 29, 2010.
U.S. Appl. No. 11/868,568, filed Oct. 8, 2007 Notice of Allowance dated Mar. 2, 2010.
U.S. Appl. No. 12/503,119, filed Jul. 15, 2009 Non-Final Office Action dated Jun. 9, 2010.
U.S. Appl. No. 12/503,119, filed Jul. 15, 2009 Notice of Allowance dated Dec. 28, 2010.
CN 2007800157415.5 Certificate of Patent for Invention dated Oct. 3, 2012.
CN 2007800157415.5 Office Action dated Feb. 6, 2012.
CN 2007800157415.5 Office Action dated Sep. 15, 2011.
EP 05709151.4 filed Mar. 3, 2005 Office Action dated Jan. 17, 2012.
EP 06796143.3 filed Oct. 3, 2006 Examination Report dated Apr. 4, 2012.
EP 06796143.3 filed Oct. 3, 2006 Office Action dated Nov. 9, 2011.